APA (7th ed.) Citation

AA, T., S, N., MD, S., JW, G., B, J., F, B., . . . J, K. (2024). Exploring the effects of extended interval dosing of natalizumab and drug concentrations on brain atrophy in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 30(2), 266. https://doi.org/10.1177/13524585231225855

Chicago Style (17th ed.) Citation

AA, Toorop, et al. "Exploring the Effects of Extended Interval Dosing of Natalizumab and Drug Concentrations on Brain Atrophy in Multiple Sclerosis." Multiple Sclerosis (Houndmills, Basingstoke, England) 30, no. 2 (2024): 266. https://doi.org/10.1177/13524585231225855.

MLA (9th ed.) Citation

AA, Toorop, et al. "Exploring the Effects of Extended Interval Dosing of Natalizumab and Drug Concentrations on Brain Atrophy in Multiple Sclerosis." Multiple Sclerosis (Houndmills, Basingstoke, England), vol. 30, no. 2, 2024, p. 266, https://doi.org/10.1177/13524585231225855.

Warning: These citations may not always be 100% accurate.